QINGDAO, CHINA, January 19, 2026 /EINPresswire.com/ — As the pharmaceutical industry continues to evolve in the wake of pandemic-driven disruptions and heightened ...

Dublin, Oct. 02, 2025 (GLOBE NEWSWIRE) -- The "Europe Active Pharmaceutical Ingredients Market Size, Share & Trends Analysis Report by Synthesis, by Manufacturer, by Type (Generic APIs, Innovative ...

In this interview, NewsMed talks to Dr. James Mencel's Guidance about Scaling Up API Processes. Could you introduce yourself and your experience in the pharmaceutical industry? I obtained a B.S. in ...

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Technological innovations throughout the past several decades have transformed the pharmaceutical manufacturing process from traditional batch production to ...

−CDMO with a Six Decades-Long Reputation for Quality and Service Doubles Its Capacity to Take on New Development Projects− MORTON GROVE, Ill.--(BUSINESS WIRE)--Regis Technologies, Inc. today announced ...

A closer look at how robotics is reshaping pharmaceutical manufacturing, from improving quality and compliance to enabling more scalable production, and where the technology is headed next.

M Second Phase of CDMO Investment Builds on 2025 $6M Expansion, Funding Facility Upgrades and Increased Capacity for Suppository, Semi-Solid, and Oral Solid Dose Capacity —— Enhancements Strengthen ...

Construction is scheduled to commence in spring 2026, with both facilities anticipated to be fully operational by 2029.

Teva Pharmaceuticals is having issues with its active pharmaceutical ingredient (API) plant in Italy serious enough that it has had to stop production. The Israeli drugmaker sent a “Dear Customer” ...